Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Leukemia

Free Subscription 21.10.2019 1 Biochem Biophys Res Commun 3 Blood 1 Genes Chromosomes Cancer 2 Int J Hematol 1 J Biol Chem 2 J Pediatr Hematol Oncol 2 Leuk Lymphoma 5 Leukemia 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Biochem Biophys Res Commun

1. ZHOU Z, Liu T, Zhang J
   Morphine activates blast-phase chronic myeloid leukemia cells and alleviates the effects of tyrosine kinase inhibitors.
   Biochem Biophys Res Commun. 2019 Oct 12. pii: S0006-291X(19)31956.
   PubMed     Text format     Abstract available
   
   

   
   Blood

2. SCHMIEGELOW K
   Yet another susceptibility variant for ALL: what's next?
   Blood. 2019;133:628-629.
   PubMed     Text format    
   
   
3. BULLINGER L
   IDH2 inhibition: another piece to the puzzle.
   Blood. 2019;133:625-626.
   PubMed     Text format    
   
   
4. SMITH CC
   Roman warfare: targeting of support cells in AML.
   Blood. 2019;133:506-507.
   PubMed     Text format    
   
   

   
   Genes Chromosomes Cancer

5. TERUI K, Toki T, Taga T, Iwamoto S, et al
   Highly sensitive detection of GATA1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.
   Genes Chromosomes Cancer. 2019 Oct 13. doi: 10.1002/gcc.22816.
   PubMed     Text format     Abstract available
   
   

   
   Int J Hematol

6. DESCHNER M, Phua C, Saini L, Xenocostas A, et al
   Muscle aches and pains: do I have leukemia?
   Int J Hematol. 2019 Oct 14. pii: 10.1007/s12185-019-02746.
   PubMed     Text format     Abstract available
   
   
7. YANADA M, Takami A, Mizuno S, Mori J, et al
   Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan.
   Int J Hematol. 2019 Oct 14. pii: 10.1007/s12185-019-02759.
   PubMed     Text format     Abstract available
   
   

   
   J Biol Chem

8. SANDOVAL JE, Huang YH, Muise A, Goodell MA, et al
   Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
   J Biol Chem. 2019;294:4898-4910.
   PubMed     Text format     Abstract available
   
   

   
   J Pediatr Hematol Oncol

9. MEHRVAR N, Abolghasemi H, Rezvany MR, Akbari ME, et al
   Characterizing Iranian Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Through Gene Expression Profiling of Common ATP Binding Cassette Transporters Subfamily C.
   J Pediatr Hematol Oncol. 2019 Oct 14. doi: 10.1097/MPH.0000000000001613.
   PubMed     Text format     Abstract available
   
   
10. DE AZEVEDO AC, Matsuda E, Cervellini JY, Prandi LR, et al
    Early Mortality in Children and Adolescents with Acute Promyelocytic Leukemia: Experience of the Boldrini Children's Center.
    J Pediatr Hematol Oncol. 2019 Oct 14. doi: 10.1097/MPH.0000000000001601.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Lymphoma

11. ZHANG P, Ruan J, Weng W, Tang Y, et al
    Overexpression of SET and MYND domain-containing protein 2 (SMYD2) is associated with poor prognosis in pediatric B lineage acute lymphoblastic leukemia.
    Leuk Lymphoma. 2019 Oct 15:1-8. doi: 10.1080/10428194.2019.1675875.
    PubMed     Text format     Abstract available
    
    
12. MELEVEEDU KS, Chen D, Nadiminti K, Sidiqi H, et al
    PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia.
    Leuk Lymphoma. 2019 Oct 12:1-4. doi: 10.1080/10428194.2019.1675880.
    PubMed     Text format    
    
    

    
    Leukemia

13. ALANAZI B, Munje CR, Rastogi N, Williamson AJK, et al
    Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0596.
    PubMed     Text format     Abstract available
    
    
14. FURSTENAU M, Bahlo J, Fink AM, Lange E, et al
    Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0597.
    PubMed     Text format    
    
    
15. QUIST-PAULSEN P, Toft N, Heyman M, Abrahamsson J, et al
    T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0598.
    PubMed     Text format     Abstract available
    
    
16. CICCONI L, Platzbecker U, Avvisati G, Paoloni F, et al
    Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0589.
    PubMed     Text format    
    
    
17. WU Z, Sun H, Liu W, Zhu H, et al
    Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemia.
    Leukemia. 2019 Oct 14. pii: 10.1038/s41375-019-0594.
    PubMed     Text format    
    
    

    
    PLoS One

18. 
    Retraction: Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1.
    PLoS One. 2019;14:e0224304.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: